Brodalumab effective for rare, severe types of psoriasis

The investigational interleukin-17 inhibitor brodalumab was safe and effective in a small phase III Japanese study of adults with two rare and severe types of psoriasis, generalized pustular...
Source: Rheumatology News - Category: Rheumatology Source Type: research